DOI:
10.1055/s-00000054
Pharmacopsychiatry
LinksClose Window
References
Traynor K.
FDA advisers wary of expanding quetiapine use: clinicians air concerns about metabolic effects, tardive dyskinesia.
Am J Health Syst Pharm 2009; 66: 880-882
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.